KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Asset Writedowns and Impairment: 2012-2019

Historic Asset Writedowns and Impairment for Opko Health (OPK) over the last 3 years, with Dec 2019 value amounting to $91.7 million.

  • Opko Health's Asset Writedowns and Impairment rose 321.27% to $91.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $105.9 million, marking a year-over-year increase of 391.09%. This contributed to the annual value of $92.4 million for FY2019, which is 324.28% up from last year.
  • Latest data reveals that Opko Health reported Asset Writedowns and Impairment of $91.7 million as of Q4 2019, which was up 13,906.87% from $655,000 recorded in Q1 2019.
  • In the past 5 years, Opko Health's Asset Writedowns and Impairment ranged from a high of $91.7 million in Q4 2019 and a low of -$8.3 million during Q4 2015.
  • For the 2-year period, Opko Health's Asset Writedowns and Impairment averaged around $38.1 million, with its median value being $21.8 million (2018).
  • Within the past 5 years, the most significant YoY rise in Opko Health's Asset Writedowns and Impairment was 3,898.95% (2015), while the steepest drop was 2,788.67% (2015).
  • Quarterly analysis of 3 years shows Opko Health's Asset Writedowns and Impairment stood at -$8.3 million in 2015, then reached $21.8 million in 2018, then soared by 321.27% to $91.7 million in 2019.
  • Its last three reported values are $91.7 million in Q4 2019, $655,000 for Q1 2019, and $21.8 million during Q4 2018.